Marianne Romeo
Corporate Officer/Principal bij MYOVANT SCIENCES LTD.
Profiel
Marianne L.
Romeo is currently the Director at Bermuda Society For Healthcare Risk Management and the Head-Global Transactions & Risk Management at Myovant Sciences Ltd.
She was previously the Director & Head-Global Transactions at Sio Gene Therapies, Inc. and held the position of Managing Director at Bowring Marsh (Bermuda) Ltd.
from 2003 to 2014.
She also worked as the Head-Global Transactions & Risk Management at Roivant Sciences Ltd.
and Roivant Sciences GmbH.
Ms. Romeo has a graduate degree from Hunter College and an undergraduate degree from Tufts University.
Actieve functies van Marianne Romeo
| Bedrijven | Functie | Begin |
|---|---|---|
| MYOVANT SCIENCES LTD. | Corporate Officer/Principal | - |
| Bermuda Society For Healthcare Risk Management | Director/Board Member | - |
Eerdere bekende functies van Marianne Romeo
| Bedrijven | Functie | Einde |
|---|---|---|
| ROIVANT SCIENCES LTD. | Corporate Officer/Principal | 01-04-2023 |
| Bowring Marsh (Bermuda) Ltd. | Chief Executive Officer | 01-01-2014 |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
| SIO GENE THERAPIES INC. | Director/Board Member | - |
Opleiding van Marianne Romeo
| Hunter College | Graduate Degree |
| Tufts University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ROIVANT SCIENCES LTD. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Health Technology |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
| Bermuda Society For Healthcare Risk Management | |
| Bowring Marsh (Bermuda) Ltd. | |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
